Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GSK $44.16 +0.00%
LOXO $25.24 +0.00%
MGNX $28.97 +0.00%
MNKD $0.99 +0.00%
MDVN $62.64 +0.00%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

GSK $44.16 +0.00%
LOXO $25.24 +0.00%
MGNX $28.97 +0.00%
MNKD $0.99 +0.00%
MDVN $62.64 +0.00%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Seattle Cancer Care Alliance Settles Oxycodone Investigation for $250K

(Puget Sound Business Journal) July 7, 2016 - The Seattle Cancer Care Alliance has agreed to pay $250,000 to settle a U.S. Justice Department investigation relating to the loss of more than 96,000 pills between 2011 and 2013.
read article 



Archway Health Partners With Coalition Of Leading Oncology Groups

(Archway Health) July 1, 2016 - Archway Health announced today that it has entered into an innovative affiliation arrangement with a leading coalition of oncology medical groups for the purpose of developing superior tools and services to help practices build and manage oncology bundled payment programs.
read corporate press release 



Results of First Study Assessing Clinical Impact of ESMO-MCBS

(ESMO) July 7, 2016 - Details of the first study by one of Europe’s largest cancer centres, the Medical University of Vienna (MUV), assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale (MCBS) in a real-life context are now available on ESMO Open.
read press release 



Japan's Eisai Weighs Legal Action In UK Cancer Drug Row

(Reuters) July 7, 2016 - Japan's Eisai said on Friday it would consider all options, including possible legal action, to fight delays in Britain's healthcare system that prevent patients from accessing one of its drugs to treat a rare form of cancer.
read article 



Roche Receives FDA Approval for Use of SurePath Preservative Fluid with Cobas HPV Test for Cervical Cancer Screening

(Yahoo! Finance) July 8, 2016 - Roche HPV test is first to be approved for use with the SurePath Preservative Fluid gynecologic cell collection medium commonly used for Pap tests.
read article 



'New Game Plan' Lies Ahead for ASCO Practice Guidelines

(Medscape Medical News) July 8, 2016 - For more than 20 years, the American Society of Clinical Oncology (ASCO) has been publishing clinical guidelines, and now the society is putting together a "game plan" to help set the stage for incorporating new therapies and approaches into clinical guidelines as quickly and as accurately as possible.
read article (free registration required) 



Proposed 2017 Medicare Physician Fee Schedule Rule Released

(ASCO in Action) July 7, 2016 - On July 7, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for 2017 Physician Reimbursement.
read article 



Kite Pharma Completes Enrollment of All Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Pivotal Multi-Center Phase 2 Study of KTE-C19 (ZUMA-1)

(Biotech 365) July 8, 2016 - Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™) products for the treatment of cancer, announced today that it has completed enrollment of 72 patients in DLBCL cohort in the Phase 2 portion of ZUMA-1.
read article 



Second, Unrelated Cancer Strikes 1 In 12 Cancer Patients

(UPI.com/HealthDay News) July 8, 2016 - A new study found that 8 percent of patients -- or one in 12 -- already diagnosed with one form of cancer end up developing a second type of unrelated cancer.
read article 



Cervical Cancer Screening In England To Use ‘More Accurate’ Viral DNA Test

(Cancer Research UK/Press Association) June 6, 2016 - The NHS cervical screening programme in England will switch to first testing women for signs of infection with the virus that causes cervical cancer, rather than initially looking for abnormal cells.
read article 



Routine Screenings Prevent Cervical Cancer in Elderly Women

(University of Illinois/Illinois News Bureau) July 7, 2016 - A new study from the University of Illinois confirms a link between routine Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.
read article 



Study Finds No Substantial Harm from Primary Care Melanoma Screening

(Brown University) July 8, 2016 - Experts concerned that primary care screening for melanomas could lead to widespread misdiagnoses or overtreatment can take comfort in the results of a new study that found no such problems.
read press release 



Cetuximab Plus RT Not Ready for Prime Time in Laryngeal Cancer

(Medscape Medical News) July 7, 2016 - Numeric if not statistically significant differences favoring inclusion of cetuximab (Erbitux, Eli Lilly & Co) in combination with radiation therapy (CRT) vs radiotherapy alone are being reported for several outcomes, including laryngectomy-free survival, in patients with laryngeal cancer.
read article (free registration required) 



Study Finds Doctors Quick To Change Practice For Breast Cancer Patients

(Kaiser Health News) July 8, 2016 - Doctors cling to comfortable, widely used medical practices, even if they’re no longer particularly effective, right? A new study disputes that popular perception.
read article 



Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma

(Pfizer) July 8, 2016 - S-TRAC is the first RCC trial of a tyrosine kinase inhibitor to prolong disease-free survival in the adjuvant setting.
read corporate press release 



HPV-Linked Cancers Still Climbing in U.S.

(U.S. News & World Report/HealthDay News) July 7, 2016 - Cancers linked to the sexually transmitted human papillomavirus (HPV) keep rising in the United States, even though most cases are preventable, health officials reported Thursday.
read article 



Juno Halts Cancer Trial Using Gene-Altered Cells After 3 Deaths

(New York Times) July 7, 2016 - Three patients in a study testing the use of genetically engineered cells as a treatment for cancer have died from swelling in the brain, dealing a setback to one of the most exciting pursuits in oncology.
read article 



Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

(Forbes) July 7, 2016 - Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold.
read article 



HPV-Related Cancers an 'Epidemic' in Men, Report Finds

(NBC News) July 7, 2016 - The number of cancers related to HPV has dramatically increased, a new government report finds. But too few people are receiving the best protection against the preventable and potentially deadly diseases of the cervix, head and neck: a vaccine given to pre-teens which could protect them later in life.
read article 



FDA Approves First HPV Test For Use With Surepath Preservative Fluid

(FDA.gov) July 7, 2016 - The U.S. Food and Drug Administration today approved the Roche cobas HPV Test as the first test for Human Papilloma Virus (HPV) that can be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.
read press release 



DuPont Ordered to Pay $5.1 mln In Trial Over Teflon-Making Chemical

(Reuters) July 6, 2016 - A U.S. jury on Wednesday ordered DuPont to pay $5.1 million to a man who said he developed testicular cancer from exposure to a toxic chemical used to make Teflon at one of its plants, according to a DuPont spokesman.
read article 



House Passes Mental Health Bill

(Wall Street Journal) July 6, 2016 - The House passed legislation Wednesday to overhaul the nation’s mental health system, the first effort by lawmakers to specifically tackle federal policies on serious mental illness.
read article (paid subscription required) 



CMS Angers Hospitals With Plans For Site-Neutral Rates In Outpatient Payment Rule

(Modern Healthcare) July 6, 2016 - The CMS has responded to calls to eliminate patient satisfaction on pain management from Medicare's value-based purchasing program. The agency angered hospitals, however, with plans to stop paying their off-campus facilities the same as hospital-based outpatient departments.
read article 



Study: Insurers' Spending On Costly Meds Soared From 2003-14

(U.S. News & World Report/Associated Press) July 6, 2016 - The latest study of medicine prices finds U.S. insurers' spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled.
read article 



Opinion: Medicine’s Next Step by Barack Obama

(Boston Globe) July 7, 2016 - Health care is always personal. As science and technology have advanced, it’s become possible to make it personalized as well, giving us the tools to better understand, prevent, and treat everyone’s individual health needs.
read article (free registration required)